| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028787037 |
| P356 | DOI | 10.1007/S00125-006-0177-8 |
| P698 | PubMed publication ID | 16518588 |
| P5875 | ResearchGate publication ID | 7258670 |
| P2093 | author name string | C Y Tan | |
| D Owens | |||
| G H Tomkin | |||
| S Lally | |||
| P2860 | cites work | Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters | Q24290568 |
| Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption | Q24539051 | ||
| Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators | Q28240961 | ||
| Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes | Q28583521 | ||
| Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption | Q28593100 | ||
| A proposed model for the assembly of chylomicrons | Q33783778 | ||
| Approaches to measuring cholesterol absorption in humans | Q35769825 | ||
| Postprandial hyperlipidemia and atherosclerosis | Q36006332 | ||
| Clinical significance of the physicochemical properties of LDL in type 2 diabetes | Q36097806 | ||
| Intestinal lipoprotein assembly | Q36125654 | ||
| The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model | Q40709956 | ||
| Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes? | Q40737939 | ||
| Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats | Q41976615 | ||
| Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? | Q43889886 | ||
| Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients | Q43889921 | ||
| Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes. | Q44037435 | ||
| Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. | Q44300036 | ||
| Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease. | Q44621504 | ||
| Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment | Q44667853 | ||
| Post-prandial triglyceride profile in a population-based sample of Type 2 diabetic patients. | Q44675296 | ||
| Daytime triglyceridemia in normocholesterolemic patients with premature atherosclerosis and in their first-degree relatives | Q44697573 | ||
| Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects | Q44707483 | ||
| Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis | Q44918053 | ||
| Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity | Q44919511 | ||
| Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis | Q45177994 | ||
| Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine | Q46056322 | ||
| Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes | Q46469985 | ||
| Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition | Q46719822 | ||
| Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides | Q47333865 | ||
| Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor | Q47950989 | ||
| Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. | Q51537747 | ||
| Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. | Q51556750 | ||
| Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes. | Q51558513 | ||
| Alterations in apolipoprotein B-48 in the postprandial state in NIDDM. | Q51592590 | ||
| Postprandial lipoproteins and progression of coronary atherosclerosis | Q57321442 | ||
| Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on sterol absorption in hypercholesterolemic subjects | Q61862747 | ||
| Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models | Q67963445 | ||
| Cholesterol metabolism in alloxan-induced diabetic rabbits | Q68767563 | ||
| Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression | Q72018329 | ||
| Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE | Q72814583 | ||
| Cholesterol absorption, synthesis, and LDL metabolism in NIDDM | Q73063336 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome | Q73563419 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | triglyceride | Q186319 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1008-16 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein | |
| P478 | volume | 49 |
| Q64259306 | A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels |
| Q57115936 | ABCG5 and ABCG8: more than a defense against xenosterols |
| Q38346985 | Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome |
| Q41433586 | An acute intake of plant stanol esters alters immune-related pathways in the jejunum of healthy volunteers. |
| Q37770113 | Atherosclerosis, diabetes and lipoproteins |
| Q34560789 | Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men |
| Q37567209 | Bisphenol A promotes cholesterol absorption in Caco-2 cells by up-regulation of NPC1L1 expression |
| Q41895783 | D-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation |
| Q41283425 | Diabetes and dyslipidemia: characterizing lipoprotein metabolism |
| Q26799589 | Dyslipidaemia of diabetes and the intestine |
| Q36978025 | Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications |
| Q42909861 | Effect of corosolic acid on dietary hypercholesterolemia and hepatic steatosis in KK-Ay diabetic mice |
| Q33831184 | Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects |
| Q43161919 | Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study |
| Q89325709 | Eggs: good or bad? |
| Q42321927 | Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy |
| Q34044763 | Epigenetic modulation of intestinal cholesterol transporter Niemann-Pick C1-like 1 (NPC1L1) gene expression by DNA methylation |
| Q33609823 | Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes |
| Q33818527 | Fatty acid- and cholesterol transporter protein expression along the human intestinal tract |
| Q40035456 | HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1. |
| Q85209378 | Human NPC1L1 Expression is Positively Regulated by PPARα |
| Q92418450 | Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9) |
| Q42928427 | Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus |
| Q46388639 | Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. |
| Q24642118 | Molecular processes that handle -- and mishandle -- dietary lipids |
| Q34019608 | NPC1L1 and cholesterol transport |
| Q58774678 | Pathophysiology of Diabetic Dyslipidemia |
| Q47663088 | Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents |
| Q50186670 | Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes. |
| Q35838266 | Protein mediators of sterol transport across intestinal brush border membrane |
| Q36093336 | Recent advances in small bowel diseases: Part II. |
| Q36749246 | Regulation of postprandial lipemia: an update on current trends |
| Q46424797 | Role of the apical and basolateral domains of the enterocyte in the regulation of cholesterol transport by a high glucose concentration. |
| Q35087116 | SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin |
| Q37413198 | Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men. |
| Q79356049 | Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann-Pick C1-like 1 mRNA |
| Q33918771 | The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes |
| Q35295065 | The chylomicron: relationship to atherosclerosis |
Search more.